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Abstract
The polyunsaturated nature of n-3 fatty acids makes them prone to oxidative damage. However, it is not clear if n-3 fatty
acids are simply a passive site for oxidative attack or if they also modulate mitochondrial reactive oxygen species (ROS)
production. The present study used fat-1 transgenic mice, that are capable of synthesizing n-3 fatty acids, to investigate the
influence of increases in n-3 fatty acids and resultant decreases in the n-6:n-3 ratio on liver mitochondrial H2O2 production
and electron transport chain (ETC) activity. There was an increase in n-3 fatty acids and a decrease in the n-6:n-3 ratio in liver
mitochondria from the fat-1 compared to control mice. This change was largely due to alterations in the fatty acid
composition of phosphatidylcholine and phosphatidylethanolamine, with only a small percentage of fatty acids in
cardiolipin being altered in the fat-1 animals. The lipid changes in the fat-1 mice were associated with a decrease (p,0.05) in
the activity of ETC complex I and increases (p,0.05) in the activities of complexes III and IV. Mitochondrial H2O2 production
with either succinate or succinate/glutamate/malate substrates was also decreased (p,0.05) in the fat-1 mice. This change
in H2O2 production was due to a decrease in ROS production from ETC complex I in the fat-1 animals. These results indicate
that the fatty acid changes in fat-1 liver mitochondria may at least partially oppose oxidative stress by limiting ROS
production from ETC complex I.
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Introduction
Considerable interest exists in the possible health benefits of
increasing dietary intake of n-3 fatty acids. It has been reported
that diets high in n-3 fatty acids can decrease the incidence of
several disease processes, including coronary heart disease [1,2],
inflammatory disorders [3], hypertension, and arthritis [1], as well
as some mood disorders [4]. Nonetheless, some have raised
questions concerning possible ill effects of consuming high levels of
these nutrients. In particular, the polyunsaturated nature of n-3
fatty acids makes them susceptible to oxidative damage and it has
been reported that supplementing rat diets with docosahexanoic
acid (DHA; 22:6 n-3) increases lipid peroxidation in the liver and
kidneys [5]. Moreover, long-lived mammalian species have
relatively high n-6:n-3 ratios [6] and low tissue DHA levels [7,8]
compared to shorter-lived mammals. The inverse correlation
between lifespan and n-6:n-3 ratio is thought to reflect a greater
potential for lipid peroxidation in the short-lived animals as a
result of higher concentrations of n-3 polyunsaturated fatty acids
(PUFA) [9]. However, several factors, including rate of reactive
oxygen species (ROS) production and levels of antioxidants can
influence oxidative stress, and the lipid environment around
membrane proteins which produce ROS may be particularly
important in determining the physiological response to n-3 fatty
acids (or changes in the n-6:n-3 ratio).
The mitochondrial inner membrane contains the enzyme
complexes of the electron transport chain (ETC). These enzymes
play a central role in energy metabolism and complexes I and III
are sites of cellular ROS production [10]. Thus, the physiological
response to alterations in membrane lipid composition would at
least partially depend on the ability of the lipids to alter either the
activity of these enzymes or the capacity of these enzymes to leak
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electrons and generate ROS. It has been clearly shown that the
activities of the ETC enzymes are dependent on specific
membrane phospholipids [11]. In particular, cardiolipin (CL) is
required for activity of complexes I [12], III [12,13], and IV
[14,15]. ETC complexes also bind phosphatidylcholine (PC) and
phosphatidylethanolamine (PE), and it has been shown that these
phospholipids are required for the optimum activity of complexes I
and III [11]. While this requirement for phospholipids has been
established, the influence of membrane n-3 fatty acids on ETC
enzyme activities and ROS production is still open to debate. It
has been shown that Complex IV activity is altered by diets that
differ in n-3 fatty acid composition [16], but little is known about
the influence of n-3 fatty acids on the activities of other ETC
enzymes. The few studies that have investigated the influence of n-
3 fatty acids on mitochondrial ROS production have been
inconsistent, reporting either decreases [17] or increases [18,19].
Additional studies are needed to gain a more complete
understanding of the role n-3 fatty acids play in modulating
mitochondrial enzyme activities and ROS production.
The recent availability of transgenic fat-1 mice [20] has
provided a unique genetic model for investigating the role that
chronic alterations in n-3 fatty acids may play in mitochondrial
ETC activity and ROS production. These mice express the fat-1
gene from C. elegans, which encodes a desaturase that uses n-6 fatty
acids as a substrate for the formation of n-3 fatty acids [21].
Transgenic fat-1 mice express this gene ubiquitously and thus
provide a model to investigate the effect of increasing tissue n-3
fatty acid levels without the need for dietary intervention to
achieve this goal. This helps avoid the challenge of developing
diets that truly differ only in the specific fatty acids of interest. The
fat-1 mice provide a good model for investigating the specific
consequences of sustained increases in formation of n-3 fatty acids
from n-6 fatty acid substrates.
The purpose of this study was to use fat-1 mice to investigate the
influence of increased n-3 fatty acid levels (and the resultant
decrease in the n-6:n-3 fatty acid ratio) on mitochondrial ROS
production and ETC enzyme activities. Since previous studies
have only measured tissue fatty acids in the fat-1 mice, this study
also determined the influence of the fat-1 gene on the fatty acid
composition and relative abundance of classes of mitochondrial
phospholipids.
Results
Lipid Analysis
Lipids from Percoll-purified liver mitochondria were separated
into five phospholipid classes: phosphatidylcholine (PC), phospha-
tidylethanolamine (PE), cardiolipin (CL), phosphatidylserine (PS),
and lysophosphatidylcholine (LYS). There were no significant
differences in the relative amounts (percent of total phospholi-
pids) of these phospholipids from control and fat-1 mitochondria
(Table S1).
The fatty acid compositions associated with each phospholipid
class are presented in Tables 1 and 2. PC, accounting for
approximately 40% of mitochondrial phospholipids, exhibited
significant decreases in percent PUFA (p,0.05) and n-6 (p,0.001)
and significant increases in percent n-3 (p,0.001), monounsatr-
uated fatty acids (MUFA) (p,0.01), and n-9 (p,0.01) in liver
mitochondria from fat-1 compared to control mice. Significant
increases (p,0.05) in n-3 and decreases in n-6 fatty acids of PE
(approximately 30% of mitochondrial phospholipids) and PS (4%
of mitochondrial phospholipids) were also observed in the
mitochondria from the fat-1 mice. These differences account for
an overall decrease (p,0.05) in the total n-6 to n-3 ratio. No
differences (p.0.05) between the groups of mice were observed for
any of the fatty acid series in CL.
There were a multitude of changes in the relative abundance of
individual fatty acids in the different phospholipid classes as a
result of fat-1 gene expression (Tables S2-S6). Significant (p,0.05)
decreases in arachidonic acid (20:4 n-6) and increase in
eicosapentaenoic acid (20:5 n-3) were observed in all phospholipid
classes from fat-1 mice. Similarly, increases (p,0.05) in eicosate-
traenoic acid (20:4 n-3) occurred in all lipid classes from fat-1
mitochondria, except for PS. Increases in the n-3 fatty acids
docosapentaenoic acid (22:5 n-3) and DHA (22:6 n-3) were also
observed in mitochondrial PC and PE from the fat-1 animals.
Coenzyme Q levels
Coenzyme Q is a critical component of the mitochondrial
electron transport chain and it can also acts as an antioxidant in
the mitochondrial membrane. To determine if fat-1 expression
influences mitochondrial function through changes in coenzyme
Q, levels of Q9, Q10 and total Q were measured in liver
mitochondria (Table 3). There were no differences (P.0.10)
between the control and fat-1 mice for Q9, Q10, total Q or
Q9/Q10.
Electron transport chain enzyme activities
Enzyme activities of the four mitochondrial ETC complexes,
Complexes I – IV (Figure 1) were analyzed. To investigate a
system which also includes coenzyme Q, we also measured
Complex I+III and Complex II+III activities. The activity of
Complex I was decreased by 19% (p,0.05) in the fat-1 compared
to control mice. In contrast, the activities of Complex III and
Complex IV were increased by 58% (p,0.01) and 27% (p,0.05),
respectively, in liver mitochondria from the fat-1 mice. The
decreased Complex I activity was not sufficient to cause an overall
decrease in Complex I+III activity, and in fact there was a 19%
increase (p,0.05) in Complex I+III activity in the fat-1 animals.
The activities of Complex II and Complex II+III were not
significantly different between control and fat-1 mice. The
activities of Complex I+III and II+III were lower than the activity
of Complex III alone. This result is expected since these assays
require electrons to be transferred from Complex I (NADH) or
Table 1. The ratios of n-6 to n-3 fatty acids and unsaturated
to saturated fatty acids in liver mitochondria from control and
fat-1 mice.
Phospholipid Class Mice n-6/n-3 Unsat/Satb
Phosphatidylcholine Control (n = 8) 2.2160.07 1.4660.03
fat-1 (n = 7) 1.5260.06a 1.5260.04
Phosphatidylethanolamine Control (n = 8) 1.7460.06 1.4960.02
fat-1 (n = 7) 1.1760.05a 1.5160.04
Cardiolipin Control (n = 6) 8.1960.44 6.7960.37
fat-1 (n = 5) 8.0061.01 7.4860.53
Phosphatidylserine Control (n = 7) 0.8860.05 0.9960.03
fat-1 (n = 6) 0.6760.11 1.0360.06
Lysophosphatidylcholine Control (n = 5) 2.8060.21 0.7560.02
fat-1 (n = 5) 1.8760.27a 0.6960.03
aIndicates a significant difference (P,0.05) between control and fat-1
mitochondria within a specific phospholipid class.
bUnsat/Sat is the ratio of unsaturated to saturated fatty acids.
doi:10.1371/journal.pone.0012696.t001
H2O2 Production in fat-1 Mice
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Complex II (succinate) to coenzyme Q and Complex III. Thus,
flux through Complex I or Complex II can constrain the activity of
Complex III. This may reflect the fact that Complexes I and II are
present at lower concentrations than Complex III in the
mitochondrial membrane [22,23], and coupling Complex III to
other enzymes may blunt the ‘‘excess’’ capacity of this enzyme.
H2O2 Production
Hydrogen peroxide production was measured in mitochondria
respiring on Complex I (pyruvate/malate, glutamate/malate),
Complex II (succinate) or Complex I+II (succinate/glutamate/
malate) linked substrates (Figure 2). In addition, inhibitors of
Complex I (rotenone) and Complex III (antimycin A) were used to
dissect sites of ROS production. The inhibitors maintain the
electron transport chain in a reduced state on the substrate side of
the inhibition. Therefore, if an inhibitor increases ROS produc-
tion, the site of ROS generation must be on the substrate side of
the inhibition. Under substrate-only conditions, a significant
decrease was observed in fat-1 H2O2 production in mitochondria
respiring on succinate (p,0.05) and succinate/glutamate/malate
(p,0.05). After addition of rotenone, fat-1 mitochondria respiring
on succinate/glutamate/malate, glutamate/malate or pyruvate/
malate produced significantly less H2O2 when compared to
controls (p,0.01). After addition of antimycin a, fat-1 H2O2
production was significantly decreased when succinate was the
substrate (p,0.001). However, with all other substrates, no
significant differences in H2O2 production following antimycin a
addition were observed between liver mitochondria from fat-1 and
control mice. The results indicate that H2O2 production was
greatly decreased in fat-1 liver mitochondria under conditions of
maximum ROS production from complex I by forward (rotenone
with complex I linked substrates) or reverse (succinate or succinate
with antimycin A) electron flow.
Proton Leak Kinetics
Mitochondrial proton leak is a major stimulator of mitochon-
drial respiration, and consequently this process can also influence
mitochondrial ROS production. To determine if the lipid changes
occurring with fat-1 expression influence mitochondrial proton
leak, liver mitochondrial proton leak kinetics were determined for
the fat-1 and control mice (Figure 3). There were no differences in
maximal leak-dependent respiration and membrane potential
(points farthest to the right in the graph) between the two groups of
mice. No differences in the proton leak kinetics plots were
observed between the fat-1 and control mice, indicating that basal
Table 2. The fatty acid composition of liver mitochondrial phospholipids from control and fat-1 mice.
Phospholipidsa Miceb %SFAa %MUFAa %PUFAa %n3 %n6 %n7 %n9
PC Control (8) 40.660.5 11.160.5 48.260.4 15.060.2 33.260.5 2.860.2 8.560.4
fat-1 (7) 39.860.7 13.960.6c 46.360.6c 18.460.6c 27.860.5c 3.960.5 10.160.2c
PE Control (8) 40.160.3 8.360.2 51.660.1 18.860.4 32.760.4 1.560.1 6.960.2
fat-1 (7) 39.960.6 9.160.5 51.060.3 23.460.6c 27.260.4c 2.160.3 7.360.4
CL Control (6) 13.060.6 19.061.0 68.061.3 7.560.4 60.561.3 8.560.3 10.560.8
fat-1 (5) 12.060.8 20.061.2 68.061.3 7.860.7 60.161.8 8.460.7 11.660.5
PS Control (7) 50.360.7 5.460.7 44.360.6 23.760.9 20.660.5 1.160.1 4.360.2
fat-1 (6) 49.461.4 12.363.1 38.362.5 23.562.4 14.760.9c 2.460.3c 9.962.8
LYS Control (5) 57.360.7 11.160.5 31.760.5 8.460.5 23.260.7 3.360.4 7.760.2
fat-1 (5) 59.361.2 12.160.6 28.561.6 10.060.4c 18.461.8 3.360.3 8.560.3c
All values are expressed as a percent of total fatty acids within a phospholipid class.
aAbbreviations: PC, phosphatidylcholine; PE, phosphatidylethanolamine; CL, cardiolipin; PS, phosphatidylserine; LYS, lysophophatidylserine; %SFA, percent saturated
fatty acids; % MUFA, percent monounsaturated fatty acids; %PUFA, percent polyunsaturated fatty acids.
bnumber in parenthesis indicates the number of animals used.
cIndicates a significant difference (P,0.05) between control and fat-1 mitochondria within a specific phospholipid class.
doi:10.1371/journal.pone.0012696.t002
Table 3. Coenzyme Q (CoQ) levels in liver mitochondria from
control and fat-1 mice.
Micea CoQ9b CoQ10b Total CoQb CoQ9/CoQ10
Control (6) 977.8691.4 206.3677.0 1184.16123.9 5.362.0
fat-1 (6) 1076.36136.5 207.26 67.8 1283.46194.8 5.561.3
anumber in parenthesis indicates the number of animals used.
bvalues are expressed as pmol/mg protein.
doi:10.1371/journal.pone.0012696.t003
Figure 1. Activities of electron transport chain complexes in
liver mitochondria from control (black bars, n =9) and fat-1
(grey bars, n =7) mice. All measurements were completed at 30uC
and activities are expressed nmol?min21?mg mitochondrial protein21.
*Indicates a significant difference (P,0.05) between control and fat-1
groups. Data are presented as means 6 SEM.
doi:10.1371/journal.pone.0012696.g001
H2O2 Production in fat-1 Mice
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proton leak was not altered in liver mitochondria from these
animals.
Lipid Peroxidation
Susceptibility of mitochondrial membranes to lipid peroxidation
was assessed by measuring loss of cis-parinaric acid (cPN)
fluorescence in response to 2,29-azobis(2-amidinopropane)
(AAPH) (Figure 4). A significant increase (P,0.05) in mitochon-
drial membrane lipid peroxidation was observed in the fat-1 mice
following stimulation of peroxidation with AAPH. This result
indicates that the increase in membrane n-3 fatty acids in the fat-1
mice is associated with an increase in susceptibility to peroxidation
when faced with an oxidative insult. It was necessary next to
determine if alterations in mitochondrial lipid peroxidation
occurred in the fat-1 animals under basal conditions. Two
methods, malondialdehyde (MDA) and 4-hydroxynonenal
(HNE), were also used to provide an indication of basal levels of
lipid peroxidation in mitochondria from the fat-1 mice (Figure 5A
and 5B). In contrast to the AAPH results, no differences (P.0.05)
in MDA or HNE levels were observed in mitochondria from the
two groups of mice. These results indicate that despite elevated n-3
levels, basal lipid peroxidation is not increased in mitochondria
from 1 year old fat-1 mice.
b-oxidation
Oxidation of palmitic acid was measured as an indicator of the
rate of b-oxidation (Figure S1). There were no differences
(P.0.05) between the two groups of mice for palmitate oxidation.
Discussion
The purpose of this study was to use transgenic fat-1 mice to
investigate the influence of increased n-3 fatty acid levels on
mitochondrial ROS production and ETC enzyme activity. To
Figure 2. Hydrogen peroxide production in liver mitochondria from control (black bars, n =7) and fat-1 (grey bars, n =5) mice. All
measurements were completed on freshly isolated mitochondria. H2O2 production was monitored in mitochondria respiring on succinate (A),
succinate/glutamate/malate (B), glutamate/malate (C), or pyruvate/malate (D). S, succinate; S/G/M, succinate/glutamate/malate; G/m, glutamate/
malate; P/M, pyruvate malate; Rot, rotenone; AA, antimycin a. *, {, {, 1 indicates significant differences (P,0.05) between control and fat-1
mitochondria respiring on succinate, succinate/glutamate/malate, glutamate/malate and pyruvate/malate, respectively. Data are presented as means
6 SEM.
doi:10.1371/journal.pone.0012696.g002
H2O2 Production in fat-1 Mice
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determine if the fat-1 mouse was an appropriate model to use for
these studies, it was first necessary to determine the mitochondrial
lipid composition of these animals. While several studies have
reported the influence of the fat-1 gene on tissue fatty acid
composition and the n-6:n-3 fatty acid ratio [24,25], we are not
aware of any studies that have measured lipid composition in
mitochondria isolated from these mice. The results of this study
showed that liver mitochondria mirrored the pattern of fatty acid
changes observed in whole liver from fat-1 mice [20,26].
Similar to previous studies investigating the influence of fat-1
gene expression on tissue fatty acids [20,26], mitochondria from
the fat-1 mice showed an increase in n-3 fatty acids and a decrease
in the ratio of n-6:n-3 fatty acids. This change in the ratio of n-6:n-
3 fatty acids was entirely attributable to fatty acid alterations in PE
and PC, which together accounted for greater than 70% of liver
mitochondrial phospholipids. Changes were limited to n-6 and n-3
fatty acids of 20 carbons in length, or greater. Measurements of
tissue fatty acids in liver [26] have also shown that changes in the
n-6:n-3 ratio are due to alterations in fatty acids of 20 carbons or
longer with no significant changes in linoleic acid. The fat-1 gene
encodes a desaturase which has been shown in Arabidopsis thaliana
to synthesize n-3 fatty acids from 18 or 20 carbon n-6 substrates
[21]. However, the fact that linoleic acid (C18:2 n-6) is not
decreased in either liver mitochondria or whole tissue [26]
indicates that 20 carbon n-6 fatty acids, such as arachidonic acid
(C20:4 n-6), are likely the primary substrates for n-3 fatty acid
synthesis.
It is interesting to note that fat-1 animals had only minor
changes in the fatty acid composition of CL, and that the few
significant changes were limited to fatty acids that constituted less
than 5% of the total fatty acids in this phospholipid. It has been
reported that the fatty acid composition of CL is extremely
sensitive to changes in dietary fatty acids [27]. In particular,
studies in rats have shown that feeding fish oil causes an increase in
DHA and a decrease in linoleic acid levels in CL from heart
[28,29] and liver [29]. These studies revealed a disparate response
in CL fatty acid composition as compared to what was observed in
the present study. The reason for these differences may reflect the
fact that the dietary-manipulation studies produced very large
changes in mitochondrial fatty acid composition. In contrast, the
fat-1 and control mice in the present study were fed the same diet
and the magnitude of the mitochondrial lipid changes were much
smaller than those reported in many of the dietary manipulation
studies. Also, studies feeding fish oil [28,29] had a significant
decrease in diet and mitochondrial linoleic acid levels while the
levels of this fatty acid were not altered in the fat-1 mice. This is of
importance, since linoleic acid is the primary fatty acid in liver
mitochondria from rats and mice fed a wide range of diets [30].
The fat-1 mouse provides a unique model for investigating changes
in the n-3 fatty acid composition of liver mitochondria that are
independent of alterations in either the amount or the fatty acid
composition of CL. The results from the fat-1 mice also
demonstrate that major alterations in mitochondrial ROS
production and ETC enzyme activities can occur with fatty acids
changes in PE and PC, and without major fatty acid changes in
CL.
It is important to note that expression of the fat-1 gene, or any
foreign gene, in mice clearly does not reflect a normal
physiological condition. The results of our study show that the
fatty acid changes which occur in the fat-1 mouse do not entirely
mimic those observed with dietary fatty acid alterations. Thus, the
fat-1 mouse and dietary lipid manipulations should be viewed as
distinct tools for manipulating membrane lipid composition.
Future studies using dietary lipid manipulations in fat-1 mice
may prove useful in helping to tease out the role of specific fatty
acid in mitochondrial function.
A few studies have used dietary fish oil to investigate the
influence of n-3 fatty acids on mitochondrial respiration
[29,31,32,33,34,35], and these studies have reported either no
change [32,34,35], decreases in some (but not all) measures using
various substrates [29,33] or increases in succinate supported
respiration [31]. However, measures of mitochondrial respiration
do not necessarily reflect changes in maximum mitochondrial
ETC activity and do not provide information about alterations in
the activity of specific ETC enzymes. It has been reported that
there is excess capacity of ETC enzymes and that large changes in
Figure 3. Liver mitochondrial proton leak kinetics in control
(filled circles, n =6) and fat-1 (open circles, n =6) mice. Proton
leak kinetics were completed with 10 mM succinate and 8 mg/mg
protein oligomycin and were titrated with 0.1–2.4 mM malonate.
Conditions used for these measurements are described in the text. Data
are presented as means 6 SEM.
doi:10.1371/journal.pone.0012696.g003
Figure 4. Susceptibility to 2,29-azobis(2-amidinopropane)
(AAPH)-induced lipid peroxidation in liver mitochondria from
control and fat-1 mice. AAPH-induced lipid peroxidation was
determined by measuring the loss in fluorescence of cis-parinaric acid
(cPN) incorporated into mitochondrial membranes. Peroxidation was
initiated by AAPH at 37uC. Values are presented as arbitrary
fluorescence units per minute for cPN. * indicates a significant
difference (P,0.05) between the control and fat-1 groups. Data are
presented as means 6 SEM.
doi:10.1371/journal.pone.0012696.g004
H2O2 Production in fat-1 Mice
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maximum ETC enzyme activities may be needed before
respiration is altered [22,36]. For this reason, it is essential to
measure the activity of individual ETC enzyme complexes to truly
determine the influence of n-3 fatty acids on the ETC. There have
been a couple of studies that have looked at the influence of n-3
fatty acids and changes in the ratio of n-6:n-3 fatty acids on the
activities of specific mitochondrial ETC enzyme complexes in liver
[16,29], and none of these studies have measured the activities of
all of four complexes (I, II, III and IV). It has been reported [16]
that liver cytochrome oxidase (Complex IV) activity in rats is
increased with short-term (25 weeks) and decreased with long-term
(60 weeks) consumption of fish oil. It has also been [29] reported
that Complex IV activity is decreased in heart mitochondria from
rats consuming a fish oil containing diet for 30 days. These fish oil
diet studies provided the animals a rather extreme diet that
contains very high levels of n-3 fatty acids, which resulted in highly
elevated levels of n-3 fatty acids as compared to those observed in
the fat-1 animals. A recent study reported that lipid peroxidation
leads to a decrease in the activities of ETC complexes III and IV
[37], and it is possible that the decreases in complex IV activity in
previous studies was due to lipid peroxidation secondary to very
large increases in membrane unsaturation. The present study was
unique in that it looked at the activities of each of the ETC enzyme
complexes, and did not focus on a single enzyme. This was
important since the results showed that the fatty acid changes in
the fat-1 mice did not cause uniform changes in the activities of
ETC enzymes. It has been reported that increases in the ratio of
complex IV to complex I enzyme activities are associated with a
decrease in ROS production and oxidative damage [38,39],
possibly by stimulating electron flux through complex I. Our
results are consistent with this conclusion and suggest that the
changes in the activities of the ETC complexes observed in the fat-
1 mice may help limit ROS production. In particular, increases in
the activities of complexes III and IV may help to stimulate
electron flow through complex I and prevent this complex from
remaining in a reduced state.
While many studies have focused on polyunsaturated fatty acids
as sites of oxidative damage, there is much less information about
the influence of n-3 fatty acids or alterations in the n-6:n-3 ratio on
mitochondrial ROS production. It has been reported that feeding
fish oil increases ROS production in rat colonocytes [18] and heart
mitochondria [40]. However, both of these studies appear to
involve increases in ROS production that may be secondary to
peroxidation of mitochondrial phospholipids. In contrast to these
findings, H2O2 production was either unchanged or decreased in
liver mitochondria from rats consuming fish oil when there was no
increase in mitochondrial oxidative damage [17]. The results of
the present study are consistent with this latter finding, and with
the notion that liver mitochondrial n-3 fatty acids may lead to a
decrease in ROS production. In particular, mitochondria from the
fat-1 mice had decreased H2O2 production (P,0.05) when
respiring on succinate/glutamate/malate or succinate alone.
Mitochondrial H2O2 production was also decreased (P,0.05)
with all substrates in these animals following the addition of
rotenone. The ETC inhibitors rotenone (complex I) and antimycin
a (complex III) were used to identify sites of mitochondrial ROS
production. The ETC inhibitors increase the redox state of the
electron carriers on the substrate side of the inhibitor and thus if a
particular inhibitor increases ROS production, the site of ROS
generation must be on the substrate side of the inhibitor [41]. The
fact that rotenone did not greatly stimulate H2O2 production in
fat-1 mitochondria respiring on complex I-linked substrates
indicates that liver complex I from these animals produced very
little ROS. It has been reported that Complex I produces ROS
from both the FMN and ubiquinone binding site [42], with the
ubiquinone binding site being the location of ROS production
during backflow of electrons from complex II into Complex I [43].
The fatty acid changes in the fat-1 mice appear to decrease ROS
production from both sites in Complex I. When antimycin a is
added to mitochondria respiring on succinate (complex II-linked
substrate) ROS production would be stimulated from both
complex III and reverse electron flow into complex I. Under
Figure 5. Basal lipid peroxidation in liver mitochondria from
control and fat-1 mice. A) Lipid peroxidation was determined by
measuring the level of malondialdehyde (MDA) in mitochondria as
described in the text. There were no differences (P.0.05) between the
control and fat-1 groups. B) Immunochemical detection of 4-
hydroxynonenal (HNE) adducts in isolated mitochondria. HNE measure-
ments were completed as described in the text. Relative densitometry
values expressed as means of four independent samples from each
group. The immunostain intensity of the control group was assigned a
value of 100 percent. There were no differences (P.0.05) between
groups. Data are presented as means 6 SEM.
doi:10.1371/journal.pone.0012696.g005
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these conditions, there was a decrease (P,0.05) in H2O2
production from the fat-1 mitochondria. This difference appears
to be solely due to a decrease in ROS production from backflow
into complex I, since no differences in H2O2 production were
observed between control and fat-1 mice when antimycin a was
added to mitochondria respiring only on complex I-linked
substrates. Taken together, these results indicate that the fatty
acid changes which occur in the fat-1 mouse decrease the ability of
complex I to leak electrons and form ROS. This is particularly
important since complex I appears to be a major site of
mitochondrial ROS production [10]. Thus, this decrease in
ROS production from complex I may serve as a protective
mechanism against oxidative stress in membranes with increased
levels of n-3 fatty acids.
The mechanism for decreased ROS production from complex I
in liver mitochondria of the fat-1 mice is not known. It has been
reported that ROS production during reverse electron flow is
highly dependent on mitochondrial proton motive force while
during forward electron flow ROS production is primarily
dependent on NADH/NAD [10]. Thus, it follows that mitochon-
drial proton leak could decrease ROS production by decreasing
both NADH/NAD and mitochondrial proton motive force. A
positive correlation between mitochondrial DHA levels and
proton leak has been reported [44], therefore, the influence of
fatty acid changes in the fat-1 mice on basal proton leak was
assessed in the present study. There was no change in basal proton
leak in liver mitochondria from the fat-1 and control mice,
indicating that increases in basal proton leak were not responsible
for the decrease in ROS production in the fat-1 mitochondria.
The mechanism responsible for decreased Complex I-linked
ROS production in the fat-1 mice could be due to either direct or
indirect actions of n-3 fatty acids on mitochondria. It is thought
that the formation of mitochondrial supercomplexes may limit
ROS production from Complex I [23], and it is possible that
alterations in n-3 fatty acids may influence supercomplex
formation. Also, it has been shown that n-3 fatty acids play a
role in regulating gene transcription[45,46] and studies in
adipocytes show that n-3 fatty acids stimulate mitochondrial
biogenesis [47]. It is possible that n-3 fatty acids could influence
ETC enzyme activities and ROS production in liver through
alterations in the transcription of genes encoding ETC proteins. It
is also important to consider that the results observed in liver could
be influenced by fat-1 expression in other tissues. Additional
studies are needed, preferably using mice that express the fat-1
gene under temporal and spatial control, to determine the
mechanism responsible for the observed changes in ETC enzyme
activity and ROS production in fat-1 mice.
Expression of the fat-1 desaturase results in elevated levels of
polyunsaturated n-3 fatty acids in tissues and mitochondria, and
this alone would be expected to increase tissue susceptibility to
oxidative damage. However, no differences in markers of basal
oxidative damage were observed in the present study between
wild-type and fat-1 mice at 1 year of age. This suggests that
adaptations occurred to allow these mice to live with elevated n-3
fatty acid levels. It has recently been shown that the activities of
catalase and superoxide dismutase are not significantly changed in
liver from fat-1 mice [48], suggesting that an upregulation of
hepatic antioxidant enzymes is not an adaptation to fat-1
expression. In contrast, the present study shows that fat-1
expression modulates mitochondrial H2O2 production. In partic-
ular, there was a decrease in complex I-linked ROS production in
the fat-1 mice. It was shown that fat-1 expression leads to
alterations in the activities of mitochondrial ETC enzymes (the
major site of mitochondrial ROS production), and these changes
could influence energy metabolism and ROS production in the fat-
1 mice.
In conclusion, this is the first study to show that expression of
the fat-1desaturase in mice, which increases n-3 fatty acids in
tissues and mitochondria, leads to alterations in ETC enzyme
activities and a dramatic decrease in ROS production from
complex I of the ETC. This decrease in ROS production may
serve as a protective mechanism against oxidative stress in
membranes containing increased amounts of n-3 fatty acids.
Materials and Methods
Materials
General laboratory chemicals and substrates were purchased
from Sigma Aldrich (St. Louis, MO), except Percoll (Pharmacia,
Piscataway, NJ), bovine serum albumin (MP Biochemicals, Santa
Ana, CA), and NADH (Roche, Indianapolis, IN).
Animals
Male heterozygous fat-1 transgenic mice were provided by Dr
Jing Kang (Department of Medicine, Massachusetts General
Hospital and Harvard Medical School) and used to establish a
breeding colony at UC Davis, from which all mice were used in
this study. The mice were group-housed (up to 4 mice per cage)
and maintained in a temperature (22–24uC) and humidity (40–
60%) controlled animal facility, with a 12 hour light:dark cycle. All
animals were fed ad libitum a Purina 5008 rodent diet, with free
access to water. The animal care and use protocol (#13138) was
approved by the UC Davis Institutional Animal Care and Use
Committee.
Mitochondrial isolation
One year old mice were euthanized by cervical dislocation, and
the liver removed immediately and weighed. All subsequent
procedures were performed at 4uC. Mitochondria were isolated
using the method of Venditti et al. [49] with some modifications.
Briefly, liver tissue was washed and minced in ice cold isolation
medium (220 mM mannitol, 70 mM sucrose, 20 mM Tris, 1 mM
EDTA, 0.1% BSA, pH 7.4), homogenized (10% w/v in isolation
medium) in an ice-cold glass-Teflon motor-driven homogenizer
and centrifuged at 500 g for 10 min in a Beckman Coulter Model
J2-21M Centrifuge. The pellet was discarded and the supernatant
was centrifuged at 10,000 g for 10 min. The resulting pellet was
re-suspended and centrifuged at 10,000 g in the above isolation
medium and this step was repeated twice. The resulting
mitochondria were washed twice with 0.15 M KCl to remove
catalase. The final mitochondrial pellet was re-suspended in
isolation medium without BSA, centrifuged as above and the
resulting final pellet re-suspended in isolation medium without
BSA and used in the experiments. A portion of this was used for
hydrogen peroxide assays and proton leak, while another portion
was used for ETC assays. The rest was further purified on Percoll
gradients and the resulting mitochondria were separated and
stored in liquid nitrogen for future lipid analysis.
Percoll gradient purification of mitochondria for lipid
analysis
To prepare mitochondria for lipid analysis, a discontinuous
Percoll gradient [50] was used, containing equal volumes of
Percoll at 18%, 30%, and 60% concentrations (v/v) in a buffer of
0.225 M mannitol, 1 mM EGTA, and 25 mM HEPES. Re-
suspended mitochondria were loaded on the gradient and
centrifuged at 8700 g for 1 hr at 4uC. After centrifugation,
mitochondria were isolated from the 30–60% interface and the
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Percoll removed via two rounds of centrifugation at 10,000 g for
10 min in isolation media without BSA, as described pre-
viously. The purified mitochondria were re-suspended in isolation
buffer and stored in liquid nitrogen until lipid analysis was
performed.
Electron transport chain (ETC) complex activities
The activities of the ETC complexes I, II, III and IV were
assessed spectrophotometrically using a Perkin Elmer Lambda 25
UV/Vis Spectrometer [51,52,53,54]. All assays were performed at
30uC using 25 mM potassium phosphate buffer, pH 7.2 (assay
buffer), in a final assay volume of 1 mL. Complex I (NADH:u-
biquinone oxidoreductase) activity was measured in the assay
buffer to which 5 mM MgCl2, 0.13 mM NADH, 65 mM
ubiquinone-1, 2 mM KCN, 2.5 mg/ml BSA, and 5 mg/ml
antimycin a were added. The assay was started by the addition
of mitochondria and the change in absorbance at 340 nm
(e=6.22 mM21cm21) due to NADH oxidation in the presence
of ubiquinone-1 was recorded for 1minute, after which 5 mg/ml
rotenone was added and the absorbance recorded for a further 2
minutes to allow for the quantification of the rotenone-sensitive
activity. Complex II (succinate:ubiquinone oxidoreductase) activity
was determined by the change in absorbance at 600 nm
(e=19.1mM21cm21) due to the reduction of 2,6-dichloropheno-
lindophenol (DCPIP). 20 mM succinate and mitochondria were
added to the assay buffer, and incubated for 10 minutes at 30uC,
followed by the addition of 5 mM MgCl2, 2 mM KCN, 5 mg/ml
antimycin A, 5 mg/ml rotenone, 50 mMDCPIP and finally 65 mM
ubiquinone-1 to start the assay. The reaction was monitored for a
further 10 minutes. Complex III (ubiquinol:ferritocytochrome c
oxidoreductase) activity was determined by the change in
absorbance at 550 nm (e=19.1 mM21cm21) due to the reduction
of oxidized ferritocytochrome c. To the assay buffer were added
5 mM MgCl2, 2 mM KCN, 5 mg/ml rotenone, 2.5 mg/ml BSA,
50 mM oxidized cytochrome c, and mitochondria. The assay was
started by adding 60 mM decylubiqunol and absorbance recorded
for one minute, taking the initial 30 seconds rate for calculation.
The assay was also performed in the presence of 5 mg/ml
antimycin a to distinguish between non-enzymic reduction of
ferricytochrome c and that due to reduction by decylubiquinone.
Decylubiquinol was prepared as described [55]. Complex IV
(cytochrome c oxidase) activity was determined by the change in
absorbance at 550 nm (e=19.1 mM21cm21) due to the oxidation
of reduced cytochrome c. 15 mM reduced cytochrome c and
mitochondria were added to the assay buffer and the reaction was
followed for 2 minutes.
The activity of complex I+III (NADH:cytochrome c oxidore-
ductase) was measured at 30uC by the change in absorbance at
550 nm (e=19.1 mM21cm21) due to the reduction of oxidized
ferricytochrome c. The assay final volume was 1 ml and
contained 50 mM potassium phosphate buffer pH 7.4, 80 mM
ferricytochrome c, 5 mM MgCl2, 100 mM NADH, 2 mM KCN
and mitochondria were added to start the reaction. After 1
minute of reading, 5 mg/ml rotenone was added and the reaction
followed for a further 2 minutes. Complex II+III (succinate:cy-
tochrome c oxidoreductase) activity at 30uC was determined by
the change in absorbance at 550 nm (e=19.1 mM21cm21) due
to the reduction of ferricytochrome c. The assay final volume was
1 ml and contained 40 mM potassium phosphate buffer, 0.5 mM
EDTA, 20 mM succinate and mitochondria. This was incubated
for 10 minutes at 30uC, after which 2 mM KCN, 5 mg/ml
rotenone and 30 mM ferricytochrome c was added to start the
reaction.
Mitochondrial Proton Leak Kinetics
Mitochondrial oxygen consumption was measured using
previously described methods [49,56]. Oxygen consumption was
measured at 30uC using a Clark-type oxygen electrode (Hansa-
tech, Norfolk, UK). All measurements were completed in duplicate
using mitochondria (0.5 mg mitochondrial protein/ml) in incuba-
tion medium (145 mM KCl, 30 mM Hepes, 5 mM KH2PO4,
3 mM MgCl2, 0.1 mM EGTA, 5 mM rotenone, and 0.4 mg
nigericin/mg mitochondrial protein, pH 7.4). Respiration was
initiated by the addition of succinate (10 mM) without ADP (state
4) or in the presence of 500 mM ADP (state 3). Respiratory control
ratio was calculated as state 3 divided state 4 respiration. This
value was 4.060.3 and 3.860.2 for the fat-1 and control mice,
respectively. Mitochondrial membrane potential was assessed
simultaneously with all measurements of oxygen consumption
[56]. Membrane potential was measured with a methyltriphenyl-
phosphonium (TPMP+) electrode using previously published
methods [57]. The TPMP+ electrode was calibrated with
sequential additions of 0.5 mM TPMP+ until a total concentration
of 2.5 mM TPMP+ was achieved. A TPMP+ binding correction of
0.4 was used for membrane potential calculations [56]. Proton leak
kinetics were determined by titrating the ETC with malonate (0.1–
2.4 mM), an inhibitor of complex II, in the presence of oligomycin
(8 mg/mg mitochondrial protein).
Electrophoresis and Western Blotting
Liver mitochondrial proteins from fat-1 and control mice were
separated on 10% Bis-Tris SDS-polyacrylamide gels using the
Invitrogen NuPAGE Electrophoresis System (Invitrogen Corpo-
ration, Carlsbad, CA) and MOPS running buffer. Proteins (3 mg
per lane) were resolved for 60 minutes at 200 V and blotted onto
nitrocellulose membranes at 20 V for 7.5 minutes using the
Invitrogen iBlot Dry Blotting System (Invitrogen Corporation,
Carlsbad, CA). Following blotting, the membranes were briefly
rinsed in TBS before blocking in Odyssey Blocking Buffer (LI-
COR Biosciences, Lincoln, Nebraska) for two hours at room
temperature. After blocking, the membranes were probed
overnight at 4uC with primary antibodies diluted in Odyssey
Blocking Buffer. A polyclonal anti-serum to 4-hydroxynonenal
(HNE) adducts was used at 1:5,000 dilution (Alpha Diagnostic,
San Antonio, TX) [58]. A monoclonal antibody to human porin
(Molecular Probes, Eugene, OR) was used as a mitochondrial
protein standard at 1:15,000 dilution [59,60]. After overnight
incubation, the membranes were washed 4 times, 5 minutes each,
with 0.1% TBST and then incubated for one hour at room
temperature with secondary antibodies. IRDye 680 Goat Anti-
Mouse and IRDye 800 Goat Anti-Rabbit fluorescent secondary
antibodies (LI-COR Biosciences, Lincoln, Nebraska) were each
used at a 1:20,000 dilution. After incubation, the membranes were
washed 4 times, 5 minutes each, with 0.1% TBST, and then
briefly rinsed with TBS to remove traces of Tween-20. The
membranes were visualized and relative quantities of the proteins
analyzed using the Odyssey Infrared Imaging System and
associated software (LI-COR Biosciences, Lincoln, Nebraska).
H2O2 assays
Hydrogen peroxide production by liver mitochondria was
determined fluorimetrically, as described previously [56,61], at
37uC, using a Perkin Elmer LS55 luminescence spectrometer, with
sample compartment equipped with stirring mechanism. The
excitation and emission wavelengths of the luminescence spec-
trometer were 320 and 400 nm, respectively The assay buffer was
10 mM potassium phosphate pH 7.4, containing 154 mM KCl,
0.1 mM EGTA, 3 mM MgCl2, 500 mg/assay p-hydroxyphenyla-
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cetic acid (PHPA), 4 units of horseradish peroxidase, plus
substrates as indicated below, in final volume of 3 ml. Substrates
used included 10 mM pyruvate/5 mM malate (P/M), 5 mM
glutamate/5 mM malate (G/M), 10 mM succinate (Suc), 10 mM
succinate/5 mM malate (Suc/M), and 10 mM succinate/5 mM
glutamate/5 mM malate (Suc/G/M), in the presence or absence
of the inhibitors rotenone (complex I) and antimycin a (complex
III). H2O2 levels were expressed as picomoles of H2O2 per minute
per milligram of protein. A standard curve was generated over a
range of H2O2 concentrations, and was used to convert the
fluorescence readings from assays into H2O2 concentrations.
Lipid Analysis
Lipid analysis was performed on Percoll-purified mitochondria
by Lipomics Technologies (Tethys Biosciences, Sacramento, CA).
Briefly, lipids were extracted from the mitochondria with
chloroform-methanol [62]. Lipid classes were separated by
preparative thin layer chromatography [63]. The lipid fractions
were scraped from the thin layer plates and methylated with 3N
methanolic hydrochloride under a nitrogen environment in a
sealed vial maintained at 100uC for 45 minutes. The resulting fatty
acid methyl esters were extracted with hexane containing 0.05%
butylated hydroxytoluene. Fatty acid methyl esters were separated
and quantified by capillary gas chromatography [63].
Coenzyme Q Determination
Coenzyme Q levels were determined by HPLC as previously
described [64]. Briefly, mitochondria were treated with 2% SDS
followed by two volumes of ethanol:isopropanol (95:5). Q was
recovered from this solution by extraction with five volumes of
hexane. After hexane evaporation, the lipid extract was re-
suspended in ethanol, dried again by speed-vac, re-suspended in
ethanol and analyzed by HPLC equipped with an electrochemical
(ESA, Chelmsford, MA) detector (2500 mV/+300 mV). Separa-
tion was carried out on a C18 column (5-mm particle, 5X0.45 cm)
with a mobile phase of n-propanol/methanol (35:65) containing
13.9 mM lithium perchlorate, at a flow rate of 1 ml/min.
Concentrations of CoQ9 and CoQ10 were calculated by
integration of peak areas and comparison with external standards
[65].
AAPH-induced Lipid Peroxidation
Membranes were assayed for susceptibility to lipid peroxidation
in an incubation medium consisting of 0.2 mM Tris-HCl buffer,
pH 7.6, 150 mg mitochondrial membranes and 3 mM cis-parinaric
acid (cPN) in a final volume of 2 ml. Peroxidation was initiated by
thermal decomposition of 2 mM 2,29-azobis(2-amidinopropane)
(AAPH) at 37uC. The loss in fluorescence of cPN incorporated into
mitochondrial membranes was employed as an indirect indicator
of AAPH-induced lipid peroxidation [66]. Fluorescence was
recorded continuously in an Aminco-Bowman Series 2 Luminis-
cence Spectrometer set at 324 nm for excitation (slit of 4 nm) and
413 nm for emission (slit of 8 nm). Peroxidation rates were
expressed as the decay in fluorescence (Arbitrary Units) per min.
Measurement of Mitochondrial MDA
Malondialdehyde (MDA) levels were measured according to
the method of Ge´rard-Monnier et al. [67] with some modifica-
tions. Briefly, the reaction mixture contained 6.6 mM N-methyl-
2-phenyl-indol (MPI), 0.015 mg/ml butylated hydroxytoluene
and 5.55% HCl. The assay was initiated by the addition of
sample (0.5–1 mg) and incubated at 45uC for 45 min. To
determine the amount of MDA, known concentrations of 1,1,3,
3-tetra-ethoxypropane (malondyaldehide bis(diethyl-acetal) (0–
20 nmol) were used.
Measurement of b-oxidation Activity
Palmitate oxidation was measured as an indicator of b-oxidation
[68]. Briefly, the reaction mixture contained 50 ml Tris/HCl,
pH 8.0, 40 mM NaCl, 2 mM KCl, 2 mM MgCl2, 1 mM DTT,
5 mM ATP, 0.2 mM L-carnitine, 0.2 mM NAD, 0.6 mM FAD,
0.12 mM CoA, 0.1 mCi [14C]palmitic acid, and 100 mg mito-
chondrial protein in a final volume of 200 ml. The reaction was
initiated by adding substrate and incubated at 37uC for 20
minutes. The reaction was terminated by adding 200 ml of 0.6N
perchloric acid followed by centrifugation. The resulting superna-
tant was extracted three times with 800 ml of N-hexane to remove
any remaining palmitate and radioactivity of the aqueous phase
was measured.
Statistical Analysis
All variables were tested for normality using the Shapiro-Wilk’s
test. Comparisons between control and fat-1 groups were
completed using an unpaired Student’s t-test. For sample groups
that did not meet the requirements for normal distribution,
comparisons between the control and fat-1 groups were completed
using the Wilcoxon’s two-sample rank test. Respiration and
membrane potential comparisons were also made between groups
using ANOVA in which the factors were animal, group (control or
fat-1) and inhibitor concentration. All statistical analysis was
performed using JMP software (SAS Institute, Cary, NC). All
results are presented as mean 6 SEM and statistical significance is
reported at P#0.05.
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Table S1 Phospholipid composition of liver mitochondria from
fat-1 and control mice.
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Table S2 Fatty acid composition of phosphatidylcholine from
liver mitochondria of control and fat-1 mice.
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Table S3 Fatty acid composition of phosphatidylethanolamine
from liver mitochondria of control and fat-1 mice.
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Table S4 Fatty acid composition of cardiolipin from liver
mitochondria of control and fat-1 mice.
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Table S5 Fatty acid composition of phosphatidylserine from
liver mitochondria of control and fat-1 mice.
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Table S6 Fatty acid composition of lysophosphatidylcholine
from liver mitochondria of control and fat-1 mice.
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Figure S1 The rate of palmitate oxidation as a measure of b-
oxidation in liver mitochondria from control and fat-1 mice.
Mitochondria were incubated with [14C] palmitic acid, as described
in the text. There were no differences (P.0.05) between groups.
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